![ASCO 2022 Conference Coverage](http://media.vumedi.com/thumbs/channel_logo/2022/5/eadfa937-de35-4504-be38-58654669525f.png.200x0_q85.png)
ASCO 2022 Conference Coverage
Breast
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 Preliminary Analysis of an Expanded Access Study of the Fixed-Dose Combination of Pertuzumab & Trastuzumab for Subcutaneous Injection for At-Home Administration in HER2+ BC During the COVID-19 Pandemic
FEATURING
Chau Dang
- 33 views
- June 21, 2022
ASCO 2022 Conference Coverage
ASCO 2022 Optimization of the Duration of Adjuvant Endocrine Therapy in Early Breast Cancer
FEATURING
Barbara Pistilli
- 29 views
- June 13, 2022
ASCO 2022 Conference Coverage
ASCO 2022 on Estradiol Levels in Premenopausal Women With HR+ BC on Ovarian Function Suppression With GnRH Agonists
FEATURING
Megan Tesch
- 2,977 views
- June 8, 2022
- 5
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 on Characterization of Alpelisib-Associated Hyperglycemia in mBC
FEATURING
Sherry Shen
- 9 views
- June 8, 2022
ASCO 2022 Conference Coverage
ASCO 2022 on Characterization of Alpelisib-Associated Hyperglycemia in mBC
FEATURING
Sherry Shen
- 357 views
- June 8, 2022
- 1